AbboMax, Inc

About:

AbboMax, a biotechnology platform, is an antibody product and service provider.

Website: http://www.abbomax.com

Top Investors: Yuan Zhou

Description:

AbboMax specializes in immunohistochemistry (IHC) and in situ hybridization (ISH) products and assay development. It provides high-quality custom service and products focusing on phosphospecific antibodies, IHC grade monoclonal antibodies, FFPE cell pellets slides, tissue/cell blocks, Tissue Microarray (TMA) and CRO services including recombinant protein, custom bio-conjugation, antibody fragmentation, Antibody Epitope Mapping (AEM), scale-up process for pharmaceutical companies and CLIA lab. All the manufacturing activities are performed in our the Silicon Valley Core Facility located in San Jose, California.

Total Funding Amount:

$2.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Jose, California, United States

Founded Date:

2005-10-30

Contact Email:

info(AT)abbomax.com

Founders:

Kelly Zhou

Number of Employees:

11-50

Last Funding Date:

2015-10-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai